Cadila Pharmaceuticals
CEP Certificates (EDQM COS List)
Cadila Pharmaceuticals
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 18
- Latest End Date -
- Data Source EDQM
- Last Updated 2026-04-17
Company Overview
Social Profiles
Company Snapshot
Cadila Pharmaceuticals
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210
India
www.cadilapharma.com/ View on MapCEP Records Timeline (18 records)
Product
Rivaroxaban, Form-I
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2025-140 - Rev 00
Substance No.
2932
Issue Date
2026-04-17
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2025-140 - Rev 00
Substance No.: 2932
Product
Fluoxetine hydrochloride
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2004-207 - Rev 08
Substance No.
1104
Issue Date
2026-03-06
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2004-207 - Rev 08
Substance No.: 1104
Product
Olanzapine, Form-I, Micronised
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2024-469 - Rev 00
Substance No.
2258
Issue Date
2025-12-18
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-469 - Rev 00
Substance No.: 2258
Product
Rupatadine fumarate, Micronised and Non-micronised
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2018-161 - Rev 03
Substance No.
2888
Issue Date
2025-04-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2018-161 - Rev 03
Substance No.: 2888
Product
Aripiprazole, Form 1
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2016-308 - Rev 02
Substance No.
2617
Issue Date
2024-12-13
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2016-308 - Rev 02
Substance No.: 2617
Product
Olmesartan medoxomil
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2022-427 - Rev 00
Substance No.
2600
Issue Date
2024-09-25
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-427 - Rev 00
Substance No.: 2600
Product
Desloratadine
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2014-173 - Rev 01
Substance No.
2570
Issue Date
2024-06-10
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-173 - Rev 01
Substance No.: 2570
Product
Loratadine
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
CEP 2007-284 - Rev 03
Substance No.
2124
Issue Date
2024-01-04
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2007-284 - Rev 03
Substance No.: 2124
Product
Sodium alendronate trihydrate
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2008-230 - Rev 04
Substance No.
1564
Issue Date
2022-09-14
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2008-230 - Rev 04
Substance No.: 1564
Product
Nebivolol hydrochloride
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R0-CEP 2022-095 - Rev 00
Substance No.
2775
Issue Date
2022-08-31
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2022-095 - Rev 00
Substance No.: 2775
Product
Celecoxib
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2015-220 - Rev 00
Substance No.
2591
Issue Date
2022-05-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2015-220 - Rev 00
Substance No.: 2591
Product
Amlodipine besilate
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2007-293 - Rev 02
Substance No.
1491
Issue Date
2021-02-26
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-293 - Rev 02
Substance No.: 1491
Product
Ondansetron hydrochloride dihydrate
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2004-209 - Rev 03
Substance No.
2016
Issue Date
2020-03-04
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2004-209 - Rev 03
Substance No.: 2016
Product
Sildenafil citrate
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2013-291 - Rev 00
Substance No.
2270
Issue Date
2019-12-16
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2013-291 - Rev 00
Substance No.: 2270
Product
Venlafaxine hydrochloride, Alternative process
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2010-334 - Rev 00
Substance No.
2119
Issue Date
2016-04-20
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2010-334 - Rev 00
Substance No.: 2119
Product
Zolpidem tartrate
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2007-222 - Rev 00
Substance No.
1280
Issue Date
2014-07-25
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-222 - Rev 00
Substance No.: 1280
Product
Venlafaxine hydrochloride
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2007-170 - Rev 01
Substance No.
2119
Issue Date
2014-06-20
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2007-170 - Rev 01
Substance No.: 2119
Product
Carvedilol
Substance
CADILA PHARMACEUTICALS LIMITED Ankleshwar IN
Certificate No.
R1-CEP 2006-083 - Rev 01
Substance No.
1745
Issue Date
2013-11-20
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2006-083 - Rev 01
Substance No.: 1745
Related Databases
-
FDA Inspections
0 View
-
EDQM CEP
18 View
-
KDMF
0 View
-
Japan DMF
0 View
-
Eudra GMP
0 View
Status Breakdown
18 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2025-140 - Rev 00
Substance No.: 2932
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.